Renal PK Study of LC350189
NCT04066712
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class
Conditions
Gout
Hyperuricemia
Interventions
DRUG:
LC350189 200 mg
Sponsor
LG Chem